Zoetis Inc - ZTS STOCK NEWS

Zoetis Inc. (NYSE: ZTS) appoints Gavin D.K. Hattersley, President and CEO of Molson Coors Beverage Company, to its Board of Directors. Hattersley brings global public company leadership and board experience, enhancing Zoetis' expansion in key markets. His appointment reflects Zoetis' commitment to innovation and customer-centric animal health solutions.

Zoetis Inc. (ZTS) will host a webcast and conference call to review first quarter 2024 financial results with CEO Kristin Peck and CFO Wetteny Joseph. Investors can access the live webcast on May 2, 2024, with a replay available later.

Zoetis Inc. (ZTS) to participate in the Barclays Global Healthcare Conference on March 14, 2024. Wetteny Joseph, CFO, to represent the company. Live webcast and replay available for investors.

Zoetis Inc. (ZTS) will participate in the Bank of America Securities 2024 Animal Health Summit with Wetteny Joseph, the CFO, presenting on February 29, 2024. The event will be live-streamed for investors and analysts.

Zoetis Inc. (NYSE: ZTS) reports revenue of $2.2 billion for Q4 2023, growing 8%, with net income of $525 million, increasing 14%. Full-year 2023 revenue is $8.5 billion, growing 6%, with net income of $2.3 billion, increasing 11%. Full-year 2024 revenue guidance is $9.075 - $9.225 billion.

Zoetis Inc. (ZTS) has declared a dividend of $0.432 per share for the second quarter of 2024, payable on June 4, 2024, to all holders of record of the Company’s common stock as of April 19, 2024.

Zoetis Inc. (ZTS) has been awarded the 2024 Catalyst Award for its global initiative 'Awareness and Action Drives Impact' aimed at advancing Diversity, Equity, and Inclusion (DE&I). As the first animal health company to receive this honor, Zoetis has demonstrated a commitment to fostering a diverse, inclusive environment. The company's efforts have resulted in significant increases in women's representation at various levels within the organization, including the Board of Directors.

The 2024 Feather in Her Cap awards ceremony honored 11 women for their outstanding career achievements in Animal Health, including Andrea J. Gonzales, Ph.D., of Zoetis, Inc. (NYSE: ZTS), and Katharina Bohnenblust, Ph.D., of Elanco Animal Health (NYSE: ELAN). Dr. Gonzales, Vice President of Global Companion Animal Therapeutics at Zoetis, was recognized for her leadership and contributions to the industry, while Dr. Bohnenblust received the 2024 High Flyer award for her accomplishments in pharmaceutical development. The awards aim to inspire the next generation of industry leaders and recognize women's achievements in Animal Health. Dr. Gonzales' passion for building an innovative R&D pipeline of animal health therapeutics and her commitment to mentoring women in the industry were highlighted, and she chose Cheff Therapeutic Riding Center in Kalamazoo, Michigan, as the recipient of a $5,000 charitable donation. Dr. Bohnenblust, who serves as a mentor for young female scientists, developed the new Elanco JAK-inhibitor formulation and manufacturing process. The Feather in Her Cap Association will reopen the nomination process in Q3 of 2024 to celebrate more outstanding women in Animal Health in 2025.

Zoetis Inc. (NYSE:ZTS) to host webcast and conference call to review Q4 and full year 2023 financial results